Largest health care pharmaceutical companies by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
AbbVie leads the 35 health care pharmaceutical companies ranked by total debt, at DKK 459.8B, ahead of Pfizer (DKK 441.4B) and Merck & Co (DKK 335.9B). Figures as of 20 Nov 2026, 03:03 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 35
- First
- AbbVieDKK 459.8B
- Median
- DKK 35.9B
- Combined market value
- DKK 33.81T
- Countries
- 10
- Not ranked
- 26no total debt on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total debt ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | DKK 459.8B | DKK 3.41T | DKK 1,931.62 | 0.86% down | 25% up | ||
| 2 | PfizerPFE · Health Care | DKK 441.4B | DKK 1.07T | DKK 187.62 | 1.85% down | 15% up | ||
| 3 | Merck & CoMRK · Health Care | DKK 335.9B | DKK 2.23T | DKK 904.77 | 3.61% down | 45% up | ||
| 4 | Johnson & JohnsonJNJ · Health Care | DKK 326.6B | DKK 4.38T | DKK 1,819.89 | 2.04% down | 34% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | DKK 307.3B | DKK 812.4B | DKK 397.44 | 2.05% down | 30% up | ||
| 6 | Eli LillyLLY · Health Care | DKK 289.6B | DKK 8.2T | DKK 9,204.52 | 2.29% down | 33% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | DKK 208.3B | DKK 466B | DKK 145.86 | 0.66% up | 51% up | ||
| 8 | AstraZenecaAZN · Health Care | DKK 201.8B | DKK 1.85T | DKK 1,194.98 | 1.87% down | 1% up | ||
| 9 | NovartisNVS · Health Care | DKK 195.7B | DKK 1.95T | DKK 1,030.19 | 2.57% down | 25% up | ||
| 10 | SanofiSNY · Health Care | DKK 141.4B | DKK 753.5B | DKK 313.78 | 2.25% down | 4% down | ||
| 11 | Novo NordiskNVO · Health Care | DKK 132.4B | DKK 1.17T | DKK 264.80 | 1.42% down | 17% down | ||
| 12 | GSKGSK · Health Care | DKK 130.7B | DKK 653B | DKK 325.77 | 1.56% down | 5% up | ||
| 13 | ViatrisVTRS · Health Care | DKK 98.2B | DKK 155.3B | DKK 135.43 | 1.97% down | 99% up | ||
| 14 | Abbott LaboratoriesABT · Health Care | DKK 88.1B | DKK 1.23T | DKK 707.62 | 0.58% down | 16% down | ||
| 15 | ZoetisZTS · Health Care | DKK 61.6B | DKK 223.6B | DKK 550.38 | 5.59% down | 26% down | ||
| 16 | Royalty PharmaRPRX · Health Care | DKK 61B | DKK 265.3B | DKK 461.34 | 1.38% down | 79% up | ||
| 17 | Jazz PharmaceuticalsJAZZ · Health Care | DKK 36.5B | DKK 103.4B | DKK 1,610.82 | 4.57% down | 41% up | ||
| 18 | GenmabGMAB · Health Care | DKK 35.9B | DKK 215.7B | DKK 349.82 | 0.75% up | 70% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | DKK 27.4B | DKK 89.5B | DKK 179.10 | 1.54% down | 26% up | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | DKK 17.5B | DKK 50.8B | DKK 145.72 | 2.24% down | 90% up | ||
| 21 | BridgeBio PharmaBBIO · Health Care | DKK 13.7B | DKK 103.8B | DKK 532.60 | 0.22% up | 21% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | DKK 13.5B | DKK 650.7B | DKK 6,290.26 | 2.35% down | 28% up | ||
| 23 | Ionis PharmaceuticalsIONS · Health Care | DKK 12.3B | DKK 30.9B | DKK 185.44 | 0.62% down | 63% down | ||
| 24 | BeOne MedicinesONC · Health Care | DKK 7B | DKK 311B | DKK 2,722.96 | 0.97% down | 16% up | ||
| 25 | Ascendis PharmaASND · Health Care | DKK 5.4B | DKK 114.4B | DKK 1,743.73 | 5.32% down | 29% up | ||
| 26 | InsmedINSM · Health Care | DKK 3.7B | DKK 215.9B | DKK 984.14 | 20.58% up | 40% down | ||
| 27 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 2.3B | DKK 62.8B | DKK 2,702.80 | 0.34% down | 27% down | ||
| 28 | Legend BiotechLEGN · Health Care | DKK 2.2B | DKK 21.3B | DKK 109.68 | 0.92% down | 41% down | ||
| 29 | CytokineticsCYTK · Health Care | DKK 2B | DKK 48.8B | DKK 350.57 | 0.27% up | 19% down | ||
| 30 | TG TherapeuticsTGTX · Health Care | DKK 1.7B | DKK 66.8B | DKK 442.00 | 1.88% down | 117% up | ||
| 31 | Cogent BiosciencesCOGT · Health Care | DKK 1.5B | DKK 32.9B | DKK 188.98 | 0.25% down | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 1.3B | DKK 84.2B | DKK 101.03 | 1.00% down | 8% up | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | DKK 1.3B | DKK 48.6B | DKK 924.32 | 1.25% up | 6% down | ||
| 34 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 737M | DKK 55.2B | DKK 795.70 | 1.88% down | 18% up | ||
| 35 | Definium TherapeuticsDFTX · Health Care | DKK 276.4M | DKK 27.5B | DKK 200.83 | 1.24% up | 168% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8125 DKK). 26 companies have no total debt on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies rank first by total debt?
AbbVie (DKK 459.8B), Pfizer (DKK 441.4B) and Merck & Co (DKK 335.9B) are the top three of the 35 health care pharmaceutical companies ranked by total debt as of 20 Nov 2026, 03:03 UTC.
How many health care pharmaceutical companies are in this ranking?
35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 35 health care pharmaceutical companies ranked by total debt have a combined market value of DKK 33.81T as of 20 Nov 2026, 03:03 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total debt”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.